Last reviewed · How we verify
Extravasation Injury from Anthracycline Injection
Approved treatments
- Razoxin
Razoxin works by chelating iron and preventing the formation of free radicals that damage heart tissue. - Zinecard · Pfizer
Zinecard works by binding to metal ions and preventing them from causing damage to DNA during anthracycline treatment. - Zinecard · M.D. Anderson Cancer Center
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Extravasation Injury from Anthracycline Injection patent landscape — cliff calendar, originator estates, attackable patents
- Extravasation Injury from Anthracycline Injection treatment landscape brief
- Extravasation Injury from Anthracycline Injection treatment updates RSS
Frequently asked questions about Extravasation Injury from Anthracycline Injection
What drugs treat Extravasation Injury from Anthracycline Injection?
Tracked treatments include Razoxin, Zinecard.
What is the treatment for Extravasation Injury from Anthracycline Injection?
Standard treatment for Extravasation Injury from Anthracycline Injection includes Razoxin, Zinecard. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Extravasation Injury from Anthracycline Injection patent cliff · Extravasation Injury from Anthracycline Injection CI report
- Treatment: Razoxin
- Treatment: Zinecard · Pfizer
- Treatment: Zinecard · M.D. Anderson Cancer Center
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing